GovChime
Notice ID: 889d74550860440aa802f9f72c77474eCombined Synopsis/Solicitation

Biological Therapeutics Product Development Subject Matter Expert Consulting Services to Support the Development of Therapeutic Biotechnology Products (Biologics)

Archived on November 27, 2021. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
6:00 PM UTC−05:00
Posted
November 10, 2021
Notice type
Combined Synopsis/Solicitation
Set-aside
Small Business Set Aside - Total
NAICS
541690: Other Scientific and Technical Consulting Services
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 25, 2026

Identifiers

Solicitation number
NIH-NINDS-CSS-22-000015
Notice ID
889d74550860440aa802f9f72c77474e

Description

Amendment 2: Two questions and answers added to Q&A document; two-page limit removed for Key Personnel Narrative, and minor adjustment made to Information/Physical Access Security document. Amendment 1: Consolidated Q&A document posted in response to questions submitted by 11/5 deadline. Revised documents also posted for Combined Synopsis/Solicitation (pgs 3-4), Statement of Work (pgs 9-10), Tech Eval Criteria (pgs 4-5), and Information/Physical Access Security (pgs 8-12). Description: The National Institute of Neurological Disorders and Stroke (NINDS) has a need for biological therapeutics development subject matter expert (SME) consulting services. SME consultants will be required to provide technical recommendations and advice that will support the translational development of novel therapeutics (Biologics) for NIH drug discovery and development programs. Several such programs are being launched or expanded to provide support for investigators developing medical interventions for neurological disorders. These include the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics) program, the NINDS Ultra-Rare Gene Therapy (URGenT) program, the Helping to End Addiction Long-term Pain Therapeutics Development Program (HEAL-PTDP), and other extramural or intramural NIH programs. The SMEs will support these biologics development programs by providing consulting services related to candidate biologics therapeutics development, current Good Manufacturing Practices (cGMP) manufacturing, and evaluation of the biologics in Phase 1 clinical trials. Please review the attachments for additional information.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

No documents available.

Lifecycle

Solicitation:NIH-NINDS-CSS-22-000015
  1. Combined Synopsis
  1. 3×
    Combined SynopsisCurrentOct 29, 2021

    Biological Therapeutics Product Development Subject Matter Expert Consulting Services to Support the Development of Therapeutic Biotechnology Products (Biologics)

    Notice 889d74550860440aa802f9f72c77474e on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

NIH-NINDS-CSS-22-000015

Archive Date

Nov 27, 2021

Office Address

Bethesda, MD, 20892